Exane Derivatives’s BorgWarner BWA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-903
Closed -$30.9K 824
2022
Q1
$30.9K Sell
903
-44
-5% -$1.64K 0.01% 624
2021
Q4
$37.6K Sell
947
-2,847
-75% -$114K 0.01% 531
2021
Q3
$144K Buy
3,794
+132
+4% +$5.25K 0.03% 470
2021
Q2
$153K Buy
+3,662
New +$161K 0.03% 475
2018
Q4
Sell
-1
Closed -$43 686
2018
Q3
$43 Hold
1
﹤0.01% 647
2018
Q2
$44 Hold
1
﹤0.01% 640
2018
Q1
$49 Hold
1
﹤0.01% 575
2017
Q4
$51 Sell
1
-1
-50% -$46 ﹤0.01% 567
2017
Q3
$102 Sell
2
-3,613
-100% -$148K ﹤0.01% 505
2017
Q2
$135K Buy
+3,615
New +$131K 0.03% 240

Other funds holding BWA

Exane Derivatives's BWA Position: Q2 2022 in Review

Exane Derivatives sold out of BorgWarner (BWA) in Q2 2022, closing a stake of 903 shares — an estimated $30.9K sold.

Exane Derivatives first reported a position in BWA in Q2 2017 and held it in 10 quarters. The position peaked at $153K in Q2 2021. 613 funds tracked by Wall St. Rank hold BWA as of Q2 2022.

  • Exane Derivatives reported no remaining BorgWarner position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 903 BorgWarner shares in Q2 2022, an estimated $30.9K.
  • Exane Derivatives first reported a position in BorgWarner in Q2 2017 and held it in 10 quarters.
  • Exane Derivatives's BorgWarner position peaked at $153K in Q2 2021.
  • 613 funds tracked by Wall St. Rank held BorgWarner as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.